维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="Jorde UP"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Elevated plasma aldosterone levels despite complete inhibition of the vascular angiotensin-converting enzyme in chronic heart failure显示文摘	Jorde UP Vittorio T Katz SD	2002	Circulation2002，106，9：	1
2	Suppression of the renin-angiotensin-aldosterone system in chronic heart failure:choice of agents and clinical impact显示文摘	Jorde UP	2006	Cardiol Rev2006，14，2：	1
3	Maximally recommended doses of angiotensin converting enzyme inhibitors do not completely prevent ACE-mediated formation of angiotensin Ⅱ in chronic heart failure显示文摘	Jorde UP Ennezat PV Lisker BA	2000	Circulation2000，101，：	1
4	Comparison of sup-pression of the circulating and vascular renin - angiotensin systemby enalapril versua trandolapril in chronic heart failure显示文摘	Jorde UP Vittorio TJ Dimayuga CA	2004	Am JCardiol2004，94，：	1
5	Suppression of the renin -angiotensin -aldosterone system in chronic heart failure: choice of agents and clinical impact 显示文摘	Jorde UP	2006	Cardiol Rev2006，14，：	1
6	Suppression of the renin-angiotensin-aldosterone system in chronic heart failure:choice of agents and clinical impact显示文摘	Jorde UP	2006	Cardiol Rev2006，14，2：	1
7	Suppression of the remin-angiotensin-aldosterone system in chronic heart failure choice of agents and clinical impact显示文摘	Jorde UP	2006	Cardiol Ren2006，14，7：	1
8	Exercise-induced increases in oxidized low-density lipoprotein are associated with adverse outcomes in chronic heart failure显示文摘	Jorde UP Colombo PC Ahuja K	2007	J Card Fail2007，13，9：	1
9	Suppression of the renin - angiotensin - aldosterone system in chronic heart failure:choice of agents and clinical impact显示文摘	Jorde UP	2006	Cardiol Rev2006，14，2：	1
10	Elevated plasma aldosterone levels despite complete inhibition of the vascular angiotensin-converting enzyme in chronic heart failure显示文摘	Vittorio T	2002	Circulation2002，106，：	1
11	Maximally recommended doses of angiotensin converting enzyme inhibitors do not completely prevent ACE-mediated formation of angiotensin Ⅱ in chronic heart failure显示文摘	Jorde UP Ennezat PV Lisker BA	2000	circulation2000，101，8：	1
12	Maximally recommended doses of angiotensin converting enzyme inhibitors do not completely prevent ACE-mediated formation of angiotensin Ⅱ in chronic heart failure显示文摘	Jorde UP Ennezat PV Lisker BA	2000	Circulation2000，101，8：	1
13	Exercise-induced increases in oxidized low density lipoprotein are associated with adverse outcomes in chronic heart failure显示文摘	Jorde UP Colombo PC Ahuja K		0，，09：	1
14	Ventricular assist device therapy 显示文摘	Sayer G Naka Y Jorde UP	2009	Cardiovasc Ther2009，27，2：	1
15	Suppression of the renin-angiotensin-aldosterone system in chronic heart failure: choice of agents and clinical impact显示文摘	Jorde UP	2006	Cardiology in Review2006，14，：	1
16	Maximally recommended doses of angiotensin converting enzyme inhibitors do not completely prevent ACE-mediated formation of angiotensin Ⅱ in chronic heart failure显示文摘	Jorde UP Ennezat PV Lisker BA	2000	Circulation2000，101，8：	1
17	Suppression of the renin-angiotensin-aldosterone system in chronic heart failure:choice of agents and clinical impact显示文摘	Jorde UP	2006	Cardiol Rev2006，14，2：	1
18	Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure显示文摘	Jorde UP Vittorio TJ Dimayuga CA	2004	Am J Cardiol2004，94，：	1
19	Suppression of the renin - angioten- sin- aldosterone system in chronic heart fail- ure : choice of agents and clinical impact 显示文摘	Jorde UP	2006	Cardiol Rev2006，14，2：	1
20	Ventricular assist device therapy 显示文摘	Sayer G Naka Y Jorde UP	2009	Cardiovasc Ther2009，27，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示